If you want an introduction to the best growth, momentum, value, international and dividend stocks while you build a diversified portfolio, this is the advisory for you.
Timothy Lutts is the Chief Analyst of Cabot Stock of the Month. He’s also Cabot’s Chief Investment Strategist, which makes him uniquely positioned to select the one stock from a range of Cabot advisories that’s most likely to outperform in the current market environment.
Cabot Stock of the Month recommends one stock each month from five other Cabot advisories, including value stocks, growth stocks, momentum stocks, dividend stocks and international stocks, depending on what appears to be the most promising stock for the current market conditions. The advisory does not present a model portfolio—i.e., there's no cash position, weightings, etc.; however, all recommendations are followed up weekly with buy, hold and eventually sell ratings. The performance shown is the gain of Cabot Stocks of the Month since inception on 8/18/2005 compared to the S&P 500 over the same time period, not including dividends, as of 5/28/15.
105% in Stryker
78% in Melco Crown Entertainment
72% in Express Scripts
69% in Salix Pharmaceuticals
Sign up now for a risk-free trial subscription to Cabot Stock of the Month. Try Cabot Stock of the Month for 12 months. If you don’t like it, you don’t pay.
Cabot Stock of the Month is an inexpensive and easy-to-follow introduction to the best growth, momentum, value, international and dividend stocks.
What our Customers say about Cabot Stock of the Month
It is your qualities of truthfulness, honesty and candor that have drawn me to the Cabot family of letters and to date, I am very pleased. The yo-yo effect of the market has not phased me. Reading your letters are like a prayer to me...they calm me.
A. Khorsandian, Daytona Beach, Florida
"Tim, I am writing to say thank you! You brought my attention to Middleby last July. At that time, I bought in at the share price of 73.59. I sold my shares on Thursday May 14 at 109.72 the recommend minimum sell price that Roy had set. I realized a return of 49% on my money in 9.5 months! I appreciate all the work you and the team does at Cabot. I am thankful to have found your company."
J. Cook, Arcadia, California
Hi Mr. Lutts, Thanks for a winner in Stryker (SYK), like others who watch your newsletters I had purchased Stryker on Cabot’s recommendation a while back and last night it hit my sell limit at 81. Nice profit for me and it will pay for more of your newsletters! I have told several friends and hopefully they will become subscribers too. Thanks again for your advice and sharing your knowledge.
Rob Rochelle, Charlotte, North Carolina
Are you ready to get started with your risk-free trial subscription?